State Ledger
Company profile

Oruka Therapeutics, Inc. CIK 907654

Ticker
ORKA (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Menlo Park, CA 94025
Fiscal year end
2025 (FY)
Market Data
Close
$80.39
Change
-$1.78
Change %
-2.17%
Volume
33,205

ORKA · trading date Oct 12, 2026 · previous close $82.17 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$105.43M
Total assets
$488.62M
Total liabilities
$16.69M
Stockholders' equity
$471.93M
Cash & equivalents
$46.94M
Operating income
-$122.05M
Operating cash flow
-$88.21M
Capital expenditures
$209.0K

Fiscal year 2025, via 10-K filed 2026-03-12. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$88.42M
Free cash flow margin
—
Liabilities / assets
3.4%
Equity / assets
96.6%
CapEx / revenue
—
Operating cash flow / net income
0.84×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$105.43M $488.62M $16.69M $471.93M
2024 — — $396.02M $13.80M $382.22M
2023 $0 -$5.34M $37.86M $841.0K $37.02M
2022 $0 -$9.93M $43.09M $1.41M $41.67M
2021 $0 -$19.32M $54.92M $3.88M $51.04M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-15
Financials filed via
Form 10-K
filed 2026-03-12

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Menlo Park, CA 94025
855 OAK GROVE AVE.
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:14 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies